8. Références (1-350)

1. M. Garnier, V. Delamare, 2002, Dictionnaire des termes de médecine. 27ème édition, Maloine.

2. Acha P.N. , Szyfres B, 2005, Zoonoses et maladies transmissibles communes à l’Homme et à l’animal, 3ème édition, O.I.E.

3. E. Pilly, 2006,  Maladies infectieuses et tropicales, 20ème  édition, Vivactis Plus.

4. Chabasse D., Robert R., Marot A., Pihet M., 2006, Candida pathogène, Lavoisier.

5. http://www.environnementsuisse.ch/buwal/fr/publikationen/

6. Eggimann P., Garbino J., Pittet D.(2003) Epidemiology de Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis., 3: 685-702

7. Mok WY, da Silva MSB, 1984, Mycdelora de the human dermal surfaces, Can J Microbiol, 30: 1205-9

8. Mok WY, Luizao RC et al., 1984, Ecology de pathogenic yeasts in Amazonian soil, Appl Environ Microbiol, 47: 390-4

9. Hagler AN, De Olivera RB, Mendonca LC, 1982, Yeasts in the intertidal sediments de a polluted estuary in Rio de Janeiro, Antonie Van Leeuwenhoek, 48(1): 53-6

10. Boiron P, Agis F, Nguyen VH, 1983, Study de yeast flora de medical interest on the beach de Saint Anne in Guadeloupe, Bull Soc Pathol Exot Filiales, 76(4): 351-6

11. Lopandic K, Zelger S, Banszky LK, Eliskases-Lechner F, Prillinger H, 2006, Identification de yeasts associated with milk products using traditional and molecular techniques, Food Microbiol, 23(4): 341-50

12. Kleinegger CL, Lockhart SR, Vargas K, Soll DR, 1996, Frequency, intensity, species and strains de oral Candida vary as a function de host age, J Clin Microbiol, 34(9): 2246-54

13. Qi QG, Hu T, Zhou XD, 2005, Frequency, species and molecular characterization de oral Candida in hosts de different age in China, J Oral Pathol Med, 34(6): 352-6

14. Collier L, Balows A, Sussman M, 1998, Medical mycology, 9ème édition, Arnold

15. Odds FC, 1988, Candida and candidosis, 2ème edition, Baillière Tindall

16. Rippon JW, 1988, Medical Mycology, 3ème edition, WB Saunders

17. Kwon-Chung KJ, Bennett JE, 1992, Medical Mycology Lea & Febiger

18. Edwards JE, 1995, Candida species, Principles and Practice of Infectious Diseases, 4ème edition, Churchill Livingstone

19. Bodey GP, 1993, Candidiasis: Pathogenesis, Diagnosis and Treatment, 2ème édition, Raven Press

20. Lucht E., Nord CE, 1996, Opportunistic oral infections in patients infected with HIV-1. Rev. Med. Microbiol. 7: 151–163

21. Ranganathan K., Hemalatha R., 2006, Oral lesions in HIV infection in developing countries: an overview, Adv Dent Res, 19:63-68

22. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB, 1997, Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS, 11(5):557-67

23. Coleman D, Sullivan D, Harrington B, Haynes K, Henman M, Shanley D, Bennett D, Moran G, McCreary C, O’Neill L, 1997, Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis, 3 Suppl 1:S96-101.

24. Sullivan D, Coleman D, 1997, Candida dubliniensis: an emerging opportunistic pathogen, Curr Top Med Mycol, 8(1-2):15-

25. Arendorf, T. M., and D. M. Walker, 1980, The prevalence and intra-oral distribution of Candida albicans in man, Arch. Oral Biol, 25:1–10.

26. Lasker, B. A., C. M. Elie, T. J. Lott, A. Espinel-Ingroff, L. Gallagher, R. J. Kuykendall, M. E. Kellum, W. R. Pruitt, D. W. Warnock, D. Rimland, M. M. McNeil, and E. Reiss, 2001, Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits, Med. Mycol, 39:341–352.

27. Sangeorzan, J. A., S. F. Bradley, X. He, L. T. Zarins, G. L. Ridenour, R. N. Tiballi, and C. A. Kauffman, 1994, Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance, Am  J Med, 97:339–346.

28. Vargas, K. G., and S. Joly, 2002, Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals, J. Clin Microbiol, 40:341–350.

29. Yun-Liang Yang, Hsiu-Jung Lo, Chien-Ching Hung, Yichun Li, 2006, Effect of prolonged HAART on oral colonization with Candida and candidiasis, BMC Infectious Diseases, 6:8

30. Martins, M. D., M. Lozano-Chiu, and J. H. Rex, 1998, Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients, Clin Infect Dis, 27: 1291–1294.

31. Lopez-Dupla, M., S. P. Mora, G. Pintado, V, O. E. Valencia, P. L. Uriol, M. A. Khamashta, and A. G. Aguado. 1992. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am. J. Gastroenterol. 87:1771–1776

32. Reef, S. E. and K. H. Mayer. 1995. Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin. Infect. Dis. 21(Suppl. 1):S99–S102.

33. Abgrall, S., I. Charreau, V. Joly, J. Bloch, and J. Reynes. 2001. Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues. Eur. J. Clin. Microbiol. Infect. Dis. 20:346–349.

34. Greenspan, D., E. Komaroff, M. Redford, J. A. Phelan, M. Navazesh, M. E. Alves, H. Kamrath, R. Mulligan, C. E. Barr, and J. S. Greenspan. 2000. Oral mucosal lesions and HIV viral load in the Women’s Interagency HIV Study (WIHS). J. Acquir. Immune. Defic. Syndr. 25:44–50.

35. Chiou, C. C., A. H. Groll, C. E. Gonzalez, D. Callender, D. Venzon, P. A. Pizzo, L. Wood, and T. J. Walsh. 2000. Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factors. Pediatr. Infect. Dis. J. 19:729–734.

36. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80–96.

37. Bonavina L,  Incarbone R,  Reitano M,  Tortorano A,  Viviani M,  Peracchia A, 2003, Candida colonization in patients with esophageal disease: a prospective clinical stud, Dis Esophagus, 16(2): 70–72

38. Chong VH, Lim CC, 2005, Human immunodeficiency virus and endoscopy: Experience of a general hospital in Singapore, J Gastroenterol Hepatol, 20:722–726.

39. Martins M D, Lozano-Chiu M, Rex J H, 1998, Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin Infect Dis 27:1291-1294

40. Nucci M, Anaissie E, 2001, Revisiting the source of candidemia: skin or gut? Clin Infect Dis, 33: 1959-1967

41. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P, 1989, Clinical significance of Candida isolated from peritoneum in surgical patients, Lancet, 16;2(8677):1437-40

42. Sobel, J. D. 1988. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N.Y. Acad. Sci. 544:547–557.

43. Kent, H. L. 1991. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 165: 1168–1175.

44. Galask R P, 1989, Vaginal colonization by bacteria and yeast, Am J Obstet Gynecol, 158:993–995.

45. Sparks J M, 1991, Vaginitis, J  Reprod Med, 36:745–752.

46. Richter S S, Galask R P, Messer S, Hollis R J, Diekema D J, Pfaller M A, 2005, Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases,  J Clin Microbiol, 43(5): 2155–2162.

47. Richards MJ, Edwards JR, Culver DH, Gaynes RP, 1999, Nosocomial infections in medical intensive care units in the United States, Crit Care Med, 27:887-892.

48. Schonebeck J, 1972, Asymptomatic candiduria. Prognosis, complications and some clinical considerations. Scand J Urol Nephrol, 6:136-46.

49.  Gubbins PO, Piscitelli SC, Danziger LH, 1993, Candidal urinary tract infections : a comprehensive review of their diagnosis and management. Pharmacotherapy, 13:110-27

50. Goldberg PK, Kozinn PJ, Wise GJ, Nouri N, Brooks RB, 1979, Incidence and significance of candiduria, JAMA, 241:582-4

51.  Chabasse D, 2001, Intérêt de la numération des levures dans les urines. Revue de la littérature et résultats préliminaires d’une enquête multicentrique réalisée dans 15 centres hospitaliers universitaires, Ann Fr Anesth Réanim, 20:400-6

52. Scerpella EC, Alhalel R, 1994, An unusual cause of acute renal failure: bilateral ureteral obstruction due to Candida tropicalis fungus balls, Clin Infect Dis, 18:440-2.

53.  Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WM, 1993, Candiduria

as an early marker of disseminated infection in critically ill surgical patients : the role of fluconazole therapy, J Trauma, 35:290-4.

54. Huang CT, Leu HS, 1995, Candiduria as an early marker of disseminated infection in critically ill surgical patients,  J Trauma, 39:616.

55. Foster KW, Ghannoum MA, Elewski BE, 2004, Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol, 50(5):748-52.

56. Kirkpatrick CH, 2001, Chronic mucocutaneous candidiasis, Pediatr Infect Dis J, 20:197–206.

57. ,Lilic D, Gravenor I, Robson N, Lammas DA, Drysdale P, Calvert JE, Cant AJ, Abinun M, 2003,  Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immun, 71(10):5690-9.

58. Melville C, Kempley S, Graham J, Berry CL, 1996,  Early onset systemic Candida infection in extremely preterm neonates. Eur J Pediatr, 155: 904–906

59. Oriel JD, Petridge BM, Denny MJ, Coleman JC, 1972, Genital yeast infections, Br Med J, 4:761–764

60. Darmstadt GL, Dinulos JG, Miller Z, 2000, Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines, Pediatrics, 105(2):438-44.

61. Ward DB, Fleischer AB Jr, Feldman SR, Krowchuk DP, 2000, Characterization of diaper dermatitis in the United States, Arch Pediatr Adolesc Med, 154:943-946.

62. Aly R, Shirley C, Cunico B, Maibach HI, 1978, Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin, J Invest Dermatol, 71:378-381.

63. Elewski BE, Charif MA, 1997, Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions, Arch Dermatol, 133:1172–1173.

64. Heikkala H, Stubbs S, 1995, The prevalence of onychomycosis in Finland, Br J Dermatol, 133:699–701.

65. Andre J, Achten G, 1987, Onychomycosis, Int J Dermatol, 26:481– 490.

66. Willemsen M, 1993, Changing pattern in superficial infections: focus on onychomycosis, J Europ Acad Dermatol Venereol, 2 (Suppl. 1), S6-S11.

67. Nolting S, Brautigam M, Weidinger G, 1994, Terbinafine in onychomycosis with involvement by nondermatophytic Fungi, Br J Dermatol, 130 (Suppl 43), 16-21.

68. Foster KW, Ghannoum MA, Elewski BE, 2004, Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002, J Am Acad Dermatol, 50(5):748-52.

69. Beck-Sagué CM, Jarvis WR, 1993, Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990, J Infect Dis, 167: 1247-1251.

70. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP, 1999,  Nosocomial bloodstream infections in United States hospitals: a three- year analysis, Clin Infect Dis 29: 239-244

71. Anaissie E, Bodey GP, Kantarjian H, Ro J, Vartivarian SE, Hopfer R, Hoy J, Rolston K, 1989,  New spectrum of fungal infections in patients with cancer, Rev Infect Dis, 11: 369-378.

72. Rex JH, Bennett JE, Sugar AM, Pappas PG, Van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD, for the Candidemia Study Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group,1994, A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia,  N Engl J Med, 331: 1325-1330.

73. Voss A, Kluytmans JAJW, Koeleman JGM, Spanjaard L, Vandenbroucke-Grauls CMJE, Verbrugh HA, Vos MC, Weersink AYL, Hoogkamp-Korstanje JAA, Meis JFGM, 1996, Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals, Eur J Clin Microb Infect Dis, 15: 909-912.

74. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Lebau B, Spence D, Krcmery V, De Pauw BE, Meunier F, 1999, The Invasive Fungal Infection Group of the EORTC: Candidemia in cancer patients. A prospective, multicenter surveillance study in Europe by the the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC), Clin Infect Dis, 28: 1071-1079

75. Pfaller MA, Jones RN, Doern GV, Fluit AC, Verhoef J, Sader HS, Messer SA, Houston A, Coffman S, Hollis RJ, and the SENTRY Participant Group (Europe), 1999, International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents, Diagn Microbiol Infect Dis, 35: 19-25.

76. Brown AE,  1990, Overview of fungal infections in cancer patients, Semin Oncol, 17(Suppl. 6):2—5.

77. Jagarlamudi R, Kumar L, Kochupillai V, Kapil A, Banerjee U, Thulkar S,  2000, Infection in acute leukemia: an analysis of 240 febrile episodes, Med Oncol, 17:111—116.

78. Anonymous,  1994, Management of deep candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party,  Intensive Care Med, 20:522—528.

79. Stratov I, Gottlieb T, Bradbury R, O’Kane GM, 1998, Candidaemia in an Australian teaching hospital: relationship to central line and TPN use, J Infect, 36:203—207.

80. Paganini H, Rodriguez BT, Santos P, Seu S, Rosanova MT, 2002, Risk factors for nosocomial candidaemia: a case—control study in children, J Hosp Infect, 50:304—308.

81. Roilides E, Kaditsoglou I, Zahides D, Bibashi E, 1997, Invasive candidosis in pediatric patients, Clin Microbiol Infect, 3:192—197.

82. Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Alvarez C, Fernandez-Mazarrasa C, Farinas MC, 2003, Candidemia in a Invasive Candida epidemiology 167 tertiary care hospital: epidemiology and factors influencing mortality, Eur J Clin Microbiol Infect Dis, 22:254—257.

83. Giamarellou H, 2002, Nosocomial cardiac infections, J Hosp Infect, 50:91–105.

84. Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, de la Bellacasa JP, Soriano E, 1992, Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review, 15(6):910-23.

85. Collignon PJ, Sorrell TC, 1983, Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers, Br Med J (Clin Res Ed), 24;287(6396):861-2

86. Kirkpatrick CH, 1994, Chronic mucocutaneous candidiasis, J. Amer. Acad. Dermatol, 31 (Suppl. 2):S14-S17.

87.  Kirkpatrick CH, 1989, Chronic mucucutaneous candidiasis, Eur. J. Clin. Microbiol. Infect. Dis. 8:448-456.

88. Coleman R., Hay RJ, 1997, Chronic mucocutaneous candidosis associated with hypothyroidism: a distinct syndrome? Br J Dermatol, 136:24-9.

89. Ahonen P, 1985, Autoimmune polyendocrinopathy candidosi ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet. 27:535-42.

90. Ishii, T, Y. Suzuki, N. Ando, N. Matsuo, T. Ogata, 2000, Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, J Clin Endocrinol Metab, 85:2922-6.

91. Pitkanen, J., V. Doucas, T. Sternsdorf, T. Nakajima, S. Aratani, K. Jensen, H. Will, P. Vahamurto, J. Ollila, M. Vihinen, H. S. Scott, S. E. Antonarakis, J. Kudoh, N. Shimizu, K. Krohn, and P. Peterson, 2000, The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem. 275:16802-9.

92. Aaltonen, J., and P. Bjorses. 1999. Cloning of the APECED gene provides new insight into human autoimmunity. Ann Med. 31:111-6.

93. Bjorses, P., M. Pelto-Huikko, J. Kaukonen, J. Aaltonen, L. Peltonen, and I. Ulmanen. 1999. Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet. 8:259-66.¨

94. Brown, J. P., B. Iranpour, and M. N. Gilmour. 1971. Monilial granuloma. Diagnosis and treatment of a case of chronic localized mucocutaneous candidiasis. Oral Surg Oral Med Oral Pathol. 31:486-92.

95. Wells, R. S., J. M. Higgs, A. MacDonald, H. Valdimarson, and P. J. L. Holt. 1972. Familial chronic mucocutaneous candidiasis. Journal of Medical Genetics. 9:302-310.

96. Gatenby, P., A. Basten, and E. Adams. 1980. Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol. 3:209-16.

97. Kaneko, F., K. Tsuchiya, Y. Miura, K. Kishiyama, Y. Kusakabe, S. Matsumoto, and M. Watanabe. 1982. Clinical observations on a case of immuno-deficiency and thymoma (Good's syndrome) associated with chronic mucocutaneous candidiasis. J Dermatol. 9:355-65.

98. Montes, L. F., R. Ceballos, M. D. Cooper, M. N. Bradley, and D. E. Bockman. 1972. Chronic mucocutaneous candidiasis, myositis, and thymoma. A new triad. JAMA. 222:1619-23.

99. Rothberg, M. S., L. Eisenbud, and S. Griboff. 1989. Chronic mucocutaneous candidiasis-thymoma syndrome. A case report. Oral Surg Oral Med Oral Pathol. 68:411-3.

100. 100.Okamoto, G. A., J. G. Hall, H. Ochs, C. Jackson, K. Rodaway, and J. Chandler. 1977. New syndrome of chronic mucocutaneous candidiasis. Birth Defects Orig Artic Ser. 13:117-25.
     

101. Harms, M., S. Gilardi, P. M. Levy, and J. H. Saurat. 1984. KID syndrome (keratitis, ichthyosis, and deafness) and chronic mucocutaneous candidiasis: case report and review of the literature. Pediatr Dermatol. 2:1-7.

102. Shiraishi, S., S. Murakami, and Y. Miki. 1994. Oral fluconazole treatment of fungating candidiasis in the keratitis, ichthyosis and deafness (KID) syndrome. Br J Dermatol. 131:904-7.

103. Goldacre, M. J., B. Watt, N. Loudon, L. J. Milne, J. D. Loudon, and M. P. Vessey. 1979. Vaginal microbial flora in normal young women. Br Med J. 1:1450-5.

104. Sobel, J. D., S. Faro, R. W. Force, B. Foxman, W. J. Ledger, P. R. Nyirjesy, R. D. Reed, and P. R. Summers. 1998. Vulvovaginal candidiasis: Epidemiological, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 178:203-211.

105. Rodin, P., and B. Kolator. 1976. Carriage of yeasts on the penis. Br Med J. 1:1123-4.

106. O'Connor, M. I., and J. D. Sobel. 1986. Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans. J Infect Dis. 154:358-63.

107. Markos, A. R., A. A. Wade, and M. Walzman. 1992. Oral sex and recurrent vulvo-vaginal candidiasis [letter] [see comments]. Genitourin Med. 68:61-2.

108. Sobel, J. D. 1997. Vaginitis. N. Engl. J. Med. 337:1896-1903.

109. Sobel, J. D., S. Faro, R. W. Force, B. Foxman, W. J. Ledger, P. R. Nyirjesy, R. D. Reed, and P. R. Summers. 1998. Vulvovaginal candidiasis: Epidemiological, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 178:203-211.

110. O’Driscoll RB, Hopkinson L, Denning DW. 2005, Mold sensitisation allergy is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med; 5: 4.

111. Targonski PV, Persky VW, Ramekrishnan V, 1995, Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol; 95: 955–961.

112. H-J Malling, B Agrell and S Croner, 1986, Diagnosis and immunotherapy of mould allergy, Allergy 41 , pp. 1673–1678.

113. Celenza A, Fothergill J, Kupek E, Shaw RJ, 1996, Thunderstorm associated asthma: a detailed analysis of environmental factors. BMJ; 312: 604–607.

114. Hemmann S, Blaser K, Crameri R, 1997, Allergens of Aspergillus fumigatus and Candida boidinii share IgEbinding epitopes. Am J Respir Crit Care Med; 156: 1956–1962.

115. Paulitsch A, Weger W, Ginter-Hanselmayer G, Marth E, Buzina W, 2006, A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria. Mycoses. 49(6):471-5.

116. Fogelmark B, Thorn J, Rylander R. , 2001, Inhalation of (1.3)- beta-D-glucan causes airway eosinophilia. Mediators Inflamm; 10: 13–19.

117. Beijer L, Thorn J, Rylander R, 2003, Mould exposure at home relates to inflammatory markers in blood. Eur Respir J; 2: 317–322.

118. Fischer G, Schwabe R, Moller M, Ostrowski R, Dott W, 1999, Species-specific production of microbial volatile organic compounds (MVOC) by airborne fungi from a compost facility. Chemosphere; 39: 795–810.

119. Akiyama K, Shida T, Yasueda H, Mita H, Yanagihara Y, Hasegawa M, Maeda Y, Yamamoto T, Takesako K, Yamaguchi H, 1996, Allergenicity of acid protease secreted by Candida albicans. Allergy. Dec;51(12):887-92

120. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM, 2006, The link between fungi and severe asthma: a summary of the evidence, Eur Respir J, 27(3):615-26.

121. Ashman, R. B., J. M. Papadimitriou, A. K. Ott, and J. R. Warmnington. 1990. Antigens and immune responses in Candida albicans infection. Immunol. Cell Biol. 68:1-13.

122. Gumowski P, Lech B, Chaves I, Girard JP. Chronic asthma and rhinitis due to Candida albicans, epidermophyton and trichophyton. Ann Allergy 1987; 59: 48–51.

123. Lee TM, Greenberger PA, Oh S, Patterson R, Roberts M, Liotta JL. Allergic bronchopulmonary candidiasis: case report and suggested diagnostic criteria. J Allergy Clin Immunol 1987; 80: 816–820.

124. Pacheco A, Cuevas M, Carbelo B, Maiz L, Pavon MJ, Perez I, Quirce S Eosinophilic lung disease associated with Candida albicans allergy. Eur Respir J. 1998 Aug;12(2):502-4.

125. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 2002 Oct;15(4):545-63. Review.

126. STEFANIE HEMMANN, KURT BLASER, and RETO CRAMERI Allergens of Aspergillus fumigatus and Candida boidinii Share IgE-binding Epitopes Am. J. Respir. Crit. Care Med., Volume 156, Number 6, December 1997, 1956-1962

127. Fratamico, P. M., W. K. Long, and H. R. Buckley. 1991. Production and characterization of monoclonal antibodies to a 58-kilodalton antigen of Aspergillus fumigatus. Infect. Immun. 59: 316-322

128. Savolainen, J., A. Koivikko, K. Kalimo, E. Nieminen, and M. Viander. 1993. Candida albicans and atopic dermatitis. Clin. Exp. Allergy 23:332–339.

129. Samaranayake LP (1991). Superficial oral fungal infections. CurrOpin Dent 1:415-422.

130.  Axell T, Samaranayake LP, Reichart PA, Olsen 1 (1997). A proposal for reclassification of oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:111-1 12.

131. Ghannoum MA, Radwan SS. Candida adherence to epithelial cells. Boca Raton, FL: CRC Press, 1990.

132. Manning DJ, Coughlin RP, Poskit EM. Candida in mouth or on dummy? Arch Dis Child 1985;60:381–2.

133. Berdicevsky I, Ben-Aryeh H, Sazargel R, et al. Oral candida in children. Oral Surg Oral Med Oral Pathol 1980;57:37–40.

134. Lucas VS. Association of psychotropic drugs, prevalence of denture-related stomatitis and oral candidosis. Community Dent Oral Epidemiol 1993;21:313–16.

135. 10 Aldred MJ, Addy M, Bagg J, et al. Oral health in the terminally ill: a cross sectional pilot survey. Spec Care Dentist 1991;11:59–62.

136. Cumming CG, Wight C, Blackwell CL, et al. Denture stomatitis in the elderly. Oral Microbiol Immunol 1990;5:82–5.

137. Holbrook WP, Hjorleifsdottir DV. Occurrence of oral Candida albicans and other yeast-like fungi in edentulous patients in geriatric units in Iceland. Gerodontics 1986;2;153–6.

138. Rodu B, Carpenter JT, Jones MR. The pathogenesis and clinical significance of cytologically detectable oral candida in acute leukaemia. Cancer 1988;62:2042–6.

139. Dupont B, Graybill JR, Armstrong D, et al. Fungal infections in AIDS patients. J Med Vet Mycol 1992; 30(suppl 1):19–28.

140. Moore-Landecker E. Fundamentals of fungi. 4th ed. Upper Saddle River (NJ): Prentice Hall; 1996.

141. Madigan MT, Martinko JM, Parker J. Brock biology of microorganisms. 9th ed. Upper Saddle River (NJ): Prentice Hall;

2000.

142. Goffeau, A., Barrell, B.G., Bussey, H., Davis, R.W., Dujon, B., Feldmann, H., Galibert, F., Hoheisel, J.D., Jacq, C., Johnston, M., et al. 1996. Life with 6000 genes. Science 274: 546, 563–567.

143. van de Peer, Y., S. Chapelle, and R. De Wachter. 1996. A quantitative map of nucleotide substitution rates in bacterial rRNA. Nucleic Acids Res. 24:3381–3391.

144.  van de Peer, Y., J. Jansen, J. De Rijk, and R. De Wachter. 1997. Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res. 25:111–116.

145. Guillot, J., and E. Gue´ho. 1995. The diversity of Malassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons. Antonie Leeuwenhoek Int. J. Genet. 67:297–314.

146. Gräser, Y., M. El Fari, R. Vilgalis, F. A. Kuijpers, G. S. de Hoog, W. Presber, and H.-J. Tietz. Phylogeny of the family Arthrodermataceae using sequence analysis of the ribosomal ITS region. Mol. Biol. Evol., in press.

147. Whittaker, R. H. 1969. New concepts of kingdoms of organisms. Science 163:150–160.

148. Gow N, Brown A, Odds F: Fungal morphogenesis and host invasion. Curr Opin Microbiol 2002, 5:366-371.

149.  Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL: Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003, 2:1053-1060.

150. Wightman R, Bates S, Amornrrattanapan P, Sudbery P: In Candida albicans, the Nim1 kinases Gin4 and Hsl1 negatively regulate pseudohypha formation and Gin4 also controls septin organization. J Cell Biol 2004, 164:581-591.

151. Warenda AJ, Konopka JB: Septin function in Candida albicans morphogenesis. Mol Biol Cell 2002, 13:2732-2746.

152. Sudbery PE: The germ tubes of Candida albicans hyphae and pseudohyphae show different patterns of septin ring localization. Mol Microbiol 2001, 41:19-31.

153. Crampin H, Finley KR, Gerami-Nejad M, Court H, Gale CA, Berman J, Sudbery PE: Candida albicans hyphae have a Spitzenkörper that is distinct from the polarisome found in yeast and pseudohyphae. J Cell Sci 2005, 118:2935-2947.

154. Sudbery P, Gow N, Berman J: The distinct morphogenic states of Candida albicans. Trends Microbiol 2004, 12:317-324.

155. Olaiya AF, Sogin SJ. 1979. Ploidy determination of Candida albicans. J. Bacteriol. 140:1043– 49

156. WhelanWL,Partridge RM, Magee PT. 1980. Heterozygosity and segregation in Candida albicans. Mol. Gen. Genet. 180:107–13

157. Riggsby WS, Torres-Bauza LJ, Wills JW, Townes TM. 1982. DNA content, kinetic complexity, and the ploidy question in Candida albicans. Mol. Cell. Biol. 2:853–62

158. Diener AC, Fink GR. 1996. DLH1 is a functional Candida albicans homologue of the meiosis-specific gene DMC1. Genetics 143:769–76

159. Leberer E, Harcus D, Broadbent ID, Clark KL, Dignard D, et al. 1996. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. USA 93:13217– 22

160. Tzung KW, Williams RM, Scherer S, Federspiel N, Jones T, et al. 2001. Genomic evidence for a complete sexual cycle in Candida albicans. Proc. Natl. Acad. Sci.USA98:3249– 53

161. Graser Y, Volovsek M, Arrington J, Schonian G, Presber W, et al. 1996. Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination. Proc. Natl. Acad. Sci. USA 93:12473–77

162. Tibayrenc M. 1997. Are Candida albicans natural populations subdivided? Trends Microbiol. 5:253–57

163. Hull CM, Raisner RM, Johnson AD. 2000. Evidence for mating of the “asexual” yeast Candida albicans in a mammalian host. Science 289:307–10

164. Magee BB, Magee PT. 2000. Induction of mating in Candida albicans by construction of MTLa and MTL_ strains. Science 289:310–13

165. Clutterbuck AJ. 1992. Sexual and parasexual genetics of Aspergillus species. Biotechnology 23:3–18

166. Durand N, Reymond P, Fevre M. 1993. Randomly amplified polymorphic DNAs assessv recombination following an induced parasexual cycle in Penicillium roqueforti. Curr. Genet. 24:417–20

167. Gu YH, Ko WH. 2000. Segregation following interspecific transfer of isolated nuclei between Phytophthora parasitica and P. capsici. Can. J. Microbiol. 46:410–16

168. Sudbery P, Gow N, Berman J: The distinct morphogenic states of Candida albicans. Trends Microbiol 2004, 12:317-324.

169.  Staib P, Morschha¨user J. Chlamydospore formation onStaib agar as a species- specific characteristic on Candida dubliniensis. Mycoses 1999; 42: 521–4.

170. Mosaid AA, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal’s Agar. J Clin Microbiol 2003; 41: 4787–9.

171. Mosca CO, Moragues MD, Llovo J, Mosaid AA, Coleman DC, Ponto´n J. Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2003; 41: 1259–62.

172. Slutsky B, Staebell M, Anderson J, Risen L, Pfaller M, Soll DR. 1987. “White-opaque transition”: a second high-frequency switching system in Candida albicans. J. Bacteriol. 169:189–97

173. Rikkerink EHA, Magee BB, Magee PT. 1988. Opaque-white phenotype transition: a programmed morphological transition in Candida albicans. J. Bacteriol. 170:895– 99

174. Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. 1999. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) inthe white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect. Immun. 67:6652– 62

175. Tsuboi R, Ogawa H, Bramono K, Richardson MD, Shankland GS, et al. 1994. Pathogenesis of superficial mycoses. J. Med. Vet. Mycol. 32(Suppl. 1):91–104

176. Anderson, J. M., and D. R. Soil. 1987. Unique phenotype of opaque cells in the white-opaque transition of Candida albicans. J. Bacteriol. 169:5579-5588.

177. Anderson, J. M., R. Mihalik, and D. R. Soil. 1990. Ultrastructure and antigenicity of the unique cell and pimple of the Candida opaque phenotype. J. Bacteriol. 172:224-235.

178. Soll DR, High-frequency switching in Candida albicans. Clin Microbiol Rev. 1992 Apr;5(2):183-203.

179. Soares, R. M. A., R. M. A. Soares, D. S. Alviano, J. Angluster, C. S. Alviano, and L. R. Travassos. 2000. Identification of sialic acids on the cell surface of Candida albicans. Biochim. Biophys. Acta 1474:262-268.

180. Bishop, C. T., F. Blank, and P. E. Gardner. 1960. The cell wall polysaccharides of Candida albicans: glucan, mannan, and chitin. Can. J. Chem. 38:869-881.

181. Rees, D. A., and W. E. Scott. 1971. Polysaccharide conformation. VI. Computer model-building for linear and branched pyranoglycans. Correlations with biological function. Preliminary assessment of inter-residue forces in aqueous solution. Further interpretation of optical rotation in terms of chain conformation. J. Chem. Soc. Ser. B 1971:469-479.

182. Chattaway, F. W., M. R. Holmes, and J. E. Barlow. 1968. Cell wall composition of the mycelial and blastospore forms of Candida albicans. J. Gen. Microbiol. 51:367-376.

183. Cassone, A. 1989. Cell wall of Candida albicans: its functions and its impact on the host. Curr. Top. Med. Mycol. 3:248–314.

184. Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55:1-20

185. Shepherd, M. G. 1987. Cell envelope of Candida albicans. Crit. Rev. Microbiol. 15:7-25

186. Shepherd, M. G., R. T. M. Poulter, and P. A. Sullivan. 1985. Candida albicans: biology, genetics, and pathogenicity. Annu. Rev. Microbiol. 39:579-614

187. Elorza, M. V., H. Rico, and R. Sentandreu. 1983. Calcofluor white alters the assembly of chitin fibrils in Saccharomyces cerevisiae and Candida albicans cells. J. Gen. Microbiol. 129:1577-1582

188. Molano, J., B. Bowers, and E. Cabib. 1980. Distribution of chitin in the yeast cell wall. An ultrastructural and chemical study. J. Cell Biol. 85:199-212

189. Kobayashi, H., N. Shibata, H. Mitobe, Y. Ohkubo, and S. Suzuki. 1989. Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch. Biochem. Biophys. 272:364-375

190. Kobayashi, H., N. Shibata, M. Nakada, S. Chaki, K. Mizugami, Y. Ohkubo, and S. Suzuki. 1990. Structural analysis of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues. Arch. Biochem. Biophys. 278:195-204

191. Kobayashi, H., M. Takaku, Y. Nishidate, S. Takahashi, M. Takikawa, N. Shibata, Y. Okawa, and S. Suzuki. 1992. Structure of the D-mannan of the pathogenic yeasts, Candida stellatoidea ATCC 20408 (type II) strain, in comparison with that of C. stellatoidea ATCC 36232 (type I) strain. Carbohydr. Res. 231:105-116

192. Kobayashi, H., N. Shibata, and S. Suzuki. 1992. Evidences for oligomannosyl residues containing both b-1,2 and a-1,2 linkages as a serotype A-specific epitope(s) in mannans of Candida albicans. Infect. Immun. 60:2106-2109

193. Poulain, D., V. Hopwood, and A. Vernes. 1985. Antigenic variability of Candida albicans. Crit. Rev. Microbiol. 12:223-270

194. Bobichon, H., D. Gache, and P. Bouchet. 1994. Ultrarapid cryofixation of Candida albicans: evidence for a fibrillar reticulated external layer and mannan channels within the cell wall. Cryo-Lett. 15:161-172.

195. Poulain, D., G. Tronchin, J. F. Dubremetz, and J. Biguet. 1978. Ultrastructure of the cell wall of Candida albicans blastospores: study of its constitutive layers by the use of a cytochemical technique revealing polysaccharides. Ann. Microbiol. (Inst. Pasteur) 129:140-153.

196. Rico, H., F. Miragall, and R. Sentandreu. 1985. Abnormal formation of Candida albicans walls produced by calcofluor white: an ultrastructural and stereologic study. Exp. Mycol. 9:241-253.

197. Yu, L., K. K. Lee, K. Ens, P. C. Doig, M. R. Carpenter, W. Staddon, R. S. Hodges, W. Paranchych, and R. T. Irvin. 1994. Partial characterization of a Candida albicans fimbrial adhesin. Infect. Immun. 62:2834-2842

198. Hazen, K. C., and B. W. Hazen. 1992. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect. Immun. 60:1499-1508

199. Kusamichi, M., T. Monodane, M. Tokunaga, and H. Koike. 1990. Influence of surrounding media on preservation of cell wall structure of Candida albicans revealed by low temperature scanning electron microscopy. J. Electron Microsc. 39:477-486

200. Lee, K. K., L. Yu, D. L. Macdonald, W. Paranchych, R. S. Hodges, and R. T. Irvin. 1996. Anti-adhesin antibodies that recognize a receptor-binding motif (adhesintope) inhibit pilus/fimbrial-mediated adherence of Pseudomonas aeruginosa and Candida albicans to asialo-GM1 receptors and human buccal epithelial cell surface receptors. Can. J. Microbiol. 42:479-486

201. Yu, L., K. K. Lee, R. S. Hodges, W. Panachych, and R. T. Irvin. 1994. Adherence of Pseudomonas aeruginosa and Candida albicans to glycosphingolipis (asialo-GM1) receptors is achieved by a conserved receptor-binding domain present on their adhesins. Infect. Immun. 62:5213-5219

202. Yu, L., K. K. Lee, W. Paranchych, R. S. Hodges, and R. T. Irvin. 1996. Use of synthetic peptides to confirm that the Pseudomonas aeruginosa PAK pilus adhesin and the Candida albicans fimbrial adhesin possess a homologous receptor-binding domain. Mol. Microbiol. 19:1107-1116

203. Eisenhaber B, Bork P, Eisenhaber F. 2001. Post-translational GPI lipid anchor modification of proteins in kingdoms of life: analysis of protein sequence data from complete genomes. Protein Eng 14: 17-25.

204. Hoyer LL. 2001. The ALS gene family of Candida albicans. Trends Microbiol 9: 176-180.

205. Klis FM, de Groot P, Hellingwerf K. 2001. Molecular organization of the cell wall of Candida albicans. Med Mycol 39: 1-8.

206. Sundstrom P. 2002. Adhesion in Candida spp. Cell Microbiol 4: 461-469.

2007. Casanova, M., M. L. Gil, L. Cardefioso, J. P. Martinez, and RI Sentandreu. 1989. Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans. Infect. Immun. 57:262-271.

208. Casanova, M., J. P. Martinez, and W. L. Chaffin. 1990. Fab fragments from a monoclonal antibody against a germ tubespecific mannoprotein block yeast-to-mycelium transition in Candida albicans. Infect. Immun. 58:3810-3812.

209. Chaffin, W. L., and D. M. Stocco. 1983. Cell wall proteins of Candida albicans. Can. J. Microbiol. 29:1438-1444.

210. Elorza, M. V., A. Murgui, and R. Sentandreu. 1985. Dimorphism in Candida albicans: contribution of mannoproteins to the architecture of yeast and mycelial cell walls. J. Gen. Microbiol. 131:2209-2216.

211. Chambers, R. S., M. J. Broughton, R. D. Cannon, A. Carne, G. W. Emerson, and P. A. Sullivan. 1993. An exo-b-(1,3)-glucanase of Candida albicans: purification of the enzyme and molecular cloning of the gene. J. Gen. Microbiol. 139:325-334.

212. Elorza, M. V., A. Marcilla, and R. Sentandreu. 1988. Wall mannoproteins of the yeast and mycelial cells of Candida albicans: nature of the glycosidic bonds and polydispersity of their mannan moieties. J. Gen. Microbiol. 134:2393-2404

213. McCreath, K. J., C. A. Specht, and P. W. Robbins. 1995. Molecular cloning and characterization of chitinase genes from Candida albicans. Proc. Natl. Acad. Sci. USA 92:2544-2548

214. McCreath, K. J., C. A. Specht, Y. Liu, and P. W. Robbins. 1996. Molecular cloning of a third chitinase gene (CHT1) from Candida albicans. Yeast 12:501-504

215. Cannon, R. D., K. Niimi, H. F. Jenkinson, and M. G. Shepherd. 1994. Molecular cloning and expression of the Candida albicans-b-N-acetylglucosaminidase (HEX1) gene. J. Bacteriol. 176:2640-2647

216. Ruiz-Herrera, J., M. Iranzo, M. V. Elorza, R. Sentandreu, and S. Mormeneo. 1995. Involvement   in the formation of covalent cross-links in the cell wall of Candida albicans. Arch. Microbiol. 164:186-193

217. Naglik, J. R., Challacombe, S. J., Hube, B. (2003). Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis. Microbiol. Mol. Biol. Rev. 67: 400-428

218. Sanglard, D., B. Hube, M. Monod, F. C. Odds, and N. A. R. Gow. 1997. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun. 65:3539-3546

219. Martinez-Lopez, R., Monteoliva, L., Diez-Orejas, R., Nombela, C., Gil, C. (2004). The GPI anchored protein CaEcm33p is required for cell wall integrity, morphogenesis and virulence in Candida albicans. Microbiology 150: 3341-3354

220. Goyal, S., and G. K. Khuller. 1992. Phospholipid composition and subcellular distribution in yeast and mycelial forms of Candida albicans. J. Med. Vet. Mycol. 30:355-362

221. Ibrahim, A. S., F. Mirbod, S. G. Filler, Y. Banno, G. T. Cole, Y. Kitajima, J. E. Edwards, Jr., Y. Nozawa, and M. A. Ghannoum. 1995. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63:1993-1998

222. Pugh, D., and R. A. Cawson. 1975. The cytochemical localization of phospholipase A and lysophospholipase in Candida albicans. Sabouraudia 13:110-115

223. Pugh, D., and R. A. Cawson. 1977. The cytochemical characterization of phospholipase in Candida albicans infecting the chick chorioallantoic membrane. Sabouraudia 15:29-35

224. Takahashi, M., Y. Banno, and Y. Nozawa. 1991. Secreted Candida albicans phospholipases: purification and characterization of two forms of lysophospholipase-transacylase. J. Med. Vet. Mycol. 29:193-204

225. Fujino S, Akiyama D, Akaboshi S, Fujita T, Watanabe Y, Tamai Y. Purification and characterization of phospholipase B from Candida utilis. Biosci Biotechnol Biochem. 2006 Feb;70(2):377-86.

226. Mirbod, F., Y. Banno, M. A. Ghannoum, A. S. Ibrahim, S. Nakashima, Y. Katajima, G. T. Cole, and Y. Nozawa. 1995. Purification and characterization of lysophospholipase-transacylase (h LPTA) from a highly virulent strain of Candida albicans. Biochim. Biophys. Acta 1257:181-188

227. Takahashi, M., Y. Banno, Y. Shikano, S. Mori, and Y. Nozawa. 1991. Purification and characterization of lysophospholipase-transacylase of pathogenic fungus Candida albicans. Biochim. Biophys. Acta 1082:161-169

228. Rüchel, R., B. Böning, and M. Borg. 1986. Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of enzyme during infection in vitro. Infect. Immun. 53:411 419

229. Hube B, Hess D, Baker CA et al. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology 2001; 147: 879–89.

230. Tsuboi R, Komatsuzaki H, Ogawa H. Induction of an extracellular esterase from Candida albicans and some of its properties. Infect Immun 1996; 64: 2936–40.

231. J. Au-Young, P. W. Robbins (1990) Isolation of a chitin synthase gene (CHS1)from Candida albicans by expression in Saccharomyces cerevisiaeMolecular Microbiology 4 (2), 197–207.

232. J. L. Chen-Wu, J. Zwicker, A. R. Bowen, P. W. Robbins (1992)  Expression of chitin synthase genes during yeast and hyphal growth phases of Candida albicans  Molecular Microbiology 6 (4), 497–502.

233. Sudoh M, Nagahashi S, Doi M, Ohta A, Takagi M, Arisawa M. Cloning of the chitin synthase 3 gene from Candida albicans and its expression during yeast-hyphal transition. Mol Gen Genet. 1993 Nov;241(3-4):351-8.

234. T Mio, T Yabe, M Sudoh, Y Satoh, T Nakajima, M Arisawa and H Yamada-OkabeRole of three chitin synthase genes in the growth of Candida albicans J. Bacteriol., Apr 1996, 2416-2419, Vol 178, No. 8

235. CE Bulawa, DW Miller, LK Henry, and JM Becker Attenuated Virulence of Chitin-Deficient Mutants of Candida albicans Proc Natl Acad Sci U S A. 1995 November 7; 92(23): 10570–10574.

236. Compendium Suisse des médicaments 2007, Documed

237. Vicente, M.F., Basilio, A., Cabello, A., Peláez, F. Microbial natural products as a source of antifungals. Clin Microbiol Infect 2003; 9: 15-32

238. Jarvis, B., Figgitt, D.P., Scott, L.J. Micafungin. Drugs 2004; 64: 969- 982.

239. Vázquez, J.A. Anidulafungin: A new echinocandin with a novel profile. Clin Ther 2005; 27: 657-673.

240. Suzuki, S., K. Isono, J. Nagatsu, T. Mizutani, Y. Kawashima, and T. Mizuno. 1965. A new antibiotic, polyoxin A. J. Antibiot. 18:131.

241. Dahn, U., H. Hagenmaier, H. Hohne, W. A. Konig, G. Wolf, and H. Zahner. 1976. Stoffwechselprodukte von Mikroorganismen. 154. Mitteilung. Nikkomycin, ein neuer Hemmstoff der Chitin-synthese bei Pilzen. Arch. Microbiol. 107:143-160.

242. Becker, J. M., N. L. Covert, P. Shenbagamurthi, A. S. Steinfeld, and F. Naider. 1983. Polyoxin D inhibits growth of zoopathogenic fungi. Antimicrob. Agents Chemother. 23:926-929.

243. Hilenski, L. L., F. Naider, and J. M. Becker. 1986. Polyoxin D inhibits colloidal gold-wheat germ agglutinin labelling of chitin in dimorphic forms of Candida albicans. J. Gen. Microbiol. 132:1441-1451.

244. Hector, R. F., B. L. Zimmer, and D. Pappagianis. 1991. Inhibitors of cell wall synthesis: nikkomycins, p. 341-353. In H. Yamaguchi et al. (ed.), Recent progress in antifungal chemotherapy. Marcel Dekker, New York.

245. Perfect, J. R., K. A. Wright, and R. F. Hector. 1991. Synergistic interaction of nikkomycin and cilofungin against diverse fungi, p. 369-379. In H. Yamaguchi et al. (ed.), Recent progress in antifungal chemotherapy. Marcel Dekker, New York.

246. Gottlieb, S., Z. Altboum, D. C. Savage, and E. Segal. 1991. Adhesion of Candida albicans to epithelial cells effect of polyoxin D. Mycopathologia 115:197-205.

247. Hector, R. F., and K. Schaller. 1992. Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob. Agents Chemother. 36:1284-1289.

248. McCarthy, P. J., P. F. Troke, and K. Gull. 1985. Mechanism of action of nikkomycin and the peptide transport system of Candida albicans. J. Gen. Microbiol. 131:775-780.

249. McCarthy, P. J., D. J. Newman, L. J. Nisbet, and W. D. Kingsbury. 1985. Relative rates of transport of peptidyl drugs by Candida albicans. Antimicrob. Agents Chemother. 28:494-499.

250. Cohen, J., F. Groyne, and M. Merchez. 1986. Nucleotide sequence and transcriptional analysis in Candida albicans and Saccharomyces cerevisiae of the C. albicans gene coding for a secreted glucoamylase. Abstracts of the 13th International Conference on Yeast Genetics and Molecular Biology. Yeast 2:S67

251. Manns, J. M., D. M. Mosser, and H. R. Buckley. 1994. Production of a hemolytic factor by Candida albicans. Infect. Immun. 62:5154–5156.

252. Chattaway, F. W., S. Shenolikar, and A. J. E. Barlow. 1974. Release of acid phosphatase and polysaccharide- and protein-containing components from surface of dimorphic forms of Candida albicans by treatment with dithiothreitol. J. Gen. Microbiol. 83:423–426.

253. Shimizu, M. T., A. O. Jorge, C. S. Unterkircher, V. Fantinato, and C. R. Paulo. 1995. Hyaluronidase and chondroitin sulphatase production by different species of Candida. J. Med. Vet. Mycol. 33:27–31.

254. Shimizu, M. T., N. Q. Almeida, V. Fantinato, and C. S. Unterkircher. 1996. Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses 39:161–167.

255. El Moudni, B., M. H. Rodier, C. Barrault, M. Ghazali, and J. L. Jacquemin. 1995. Purification and characterisation of a metallopeptidase of Candida albicans. J. Med. Microbiol. 43:282–288.

256. Molina, M., R. Cenamor, M. Sa´nchez, and C. Nombela. 1989. Purification and some properties of Candida albicans exo-1,3-b-glucanase. J. Gen. Microbiol. 135:309–314.

257. Casanova, M., M. L. Gil, L. Carden˜oso, J. P. Martı´nez, and R. Sentandreu. 1989. Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans. Infect. Immun. 57:262–271.

258. Marot-Leblond, A., R. Robert, J. Aubry, P. Ezcurra, and J.-M. Senet. 1993. Identification and immunochemical characterization of a germ tube specific antigen of Candida albicans. FEMS Immunol. Med. Microbiol. 7:175–186.

259. Lo´pez-Ribot, J. L., J. P. Martı´nez, and W. L. Chaffin. 1995. Comparative study of the C3d receptor and 58-kilodalton fibrinogen-binding mannoproteins of Candida albicans. Infect. Immun. 63:2126–2132.

260. Staab, J. F., C. A. Ferrer, and P. Sundstrom. 1996. Developmental expression of a tandemly repeated, proline-and glutamine-rich amino acid motif on hyphal surfaces of Candida albicans. J. Biol. Chem. 271:6298–6305.

261. Bailey, D. A., P. J. F. Feldman, M. Bovey, N. A. R. Gow, and A. J. P. Brown. 1996. The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J. Bacteriol. 178:5353–5360.

262. Alloush, H. M., J. L. Lo´pez-Ribot, and W. L. Chaffin. 1996. Dynamic expression of cell wall proteins of Candida albicans revealed by probes from cDNA clones. J. Med. Vet. Mycol. 34:91–97.

263. Deslauriers, N. J. Michaud, B. Carre´, and C. Le´veille´e. 1996. Dynamic expression of cell-surface antigens probed with Candida albicans-specific monoclonal antibodies. Microbiology 142:1239–1248.

264. La Valle, R., C. Bromuro, L. Ranucci, H. M. Muller, A. Crisanti, and A. Cassone. 1995. Molecular cloning and expression of a 70-kilodalton heat shock protein of Candida albicans. Infect. Immun. 63:4039–4045.

265. Matthews, R. C., C. Wells, and J. P. Burnie. 1988. Characterisation and cellular localisation of the immunodominant 47-kDa antigen of Candida albicans. J. Med. Microbiol. 27:227–232.

266. Angiolella, L., M. Facchin, A. Stringaro, B. Maras, N. Simonetti, and A. Cassone. 1996. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J. Infect. Dis. 173:684–690.

267. Alloush, H. M., J. L. Lo´pez-Ribot, B. J. Masten, and W. L. Chaffin. 1997. 3-Phosphoglycerate kinase: a glycolytic enzyme present in the cell wall of Candida albicans. Microbiology 143:321–330.

268. Gil-Navarro, I., M. L. Gil, M. Casanova, J. P. Martı´nez, and D. Gozalbo. 1997. The glycolytic enzyme glyceraldehyde-3-phosphate-dehydrogenase of Candida albicans is a surface antigen. J. Bacteriol. 179:4992–4999.

269. Shen, H. D., K. B. Choo, H. H. Lee, J. C. Hsieh, W. L. Lin, W. R. Lee, and S. H. Han. 1991. The 40-kilodalton allergen of Candida albicans is an alcohol dehydrogenase: molecular cloning and immunological analysis using monoclonal antibodies. Clin. Exp. Allergy 21:675–681.

270. Hoyer, L. L., S. Scherer, A. R. Shatzman, and G. P. Livi. 1995. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol. Microbiol. 15:39–54.

271. Mager, W. H., and P. Moradas-Ferreira. 1993. Stress response of yeast. Biochem. J. 290:1–13.

272. morphogenetic processes in fungi. EMBO J. 16:1982–1991. 517. Strockbine, N. A., M. T. Largen, S. M. Zweibel, and H. R. Buckley. 1984. Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect. Immun. 43:715– 721.

273. Gil-Navarro, I., M. L. Gil, M. Casanova, J. P. Martı´nez, and D. Gozalbo. 1997. The glycolytic enzyme glyceraldehyde-3-phosphate-dehydrogenase of Candida albicans is a surface antigen. J. Bacteriol. 179:4992–4999.

274. Ishiguro, A., M. Homma, S. Torii, and K. Tanaka. 1992. Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect. Immun. 60:1550–1557.

274. Segal, E., I. Kremer, and D. Dayan. 1992. Inhibition of adherence of Candida albicans to acrylic by a chitin derivative. Eur. J. Epidemiol. 8:350– 355

275. Olson, E. J., J. E. Standing, N. Griego-Harper, O. A. Hoffman, and A. H. Limper. 1996. Fungal b-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages. Infect. Immun. 64:3548–3554.

276. Ghannoum, M. A., G. R. Burns, K. A. Elteen, and S. S. Radwan. 1986. Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells. Infect. Immun. 54:189–193.

277. Casanova, M., J. L. Lo´pez-Ribot, C. Monteagudo, A. Llombart-Bosch, R. Sentandreu, and J. P. Martı´nez. 1992. Identification of a 58 kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect. Immun. 60:4221–4229.

278 Bouali, A., R. Robert, G. Tronchin, and J. M. Senet. 1987. Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of Candida albicans. J. Gen. Microbiol. 133:545–551.

279. Lo´pez-Ribot, J. L., M. Casanova, C. Monteagudo, P. Sepu´lveda, and J. P. Martinez. 1994. Evidence for the presence of a high-affinity laminin receptor- like molecule on the surface of Candida albicans yeast cells. Infect. Immun. 62:742–746.

280. Jakab, E., M. Paulsson, F. Ascencio, and A. Ljungh. 1993. Expression of vitronectin and fibronectin binding by Candida albicans yeast cells. APMIS 101:187–193.

281. Klotz, S. A., M. J. Rutten, R. L. Smith, S. R. Babcock, and M. D. Cunning-  ham. 1993. Adherence of Candida albicans to immobilized extracellular matrix proteins is mediated by calcium-dependent surface glycoproteins. Microb. Pathog. 14:133–147.

282. Lopez-Ribot, J. L., and W. L. Chaffin. 1994. Binding of the extracellular matrix component entactin to Candida albicans. Infect. Immun. 62:4564– 4571.

283. Limper, A. H., and J. E. Standing. 1994. Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol Lett 42:139–144.

284. Critchley, I. A., and L. J. Douglas. 1987. Isolation and partial characterization of an adhesin from Candida albicans. J. Gen. Microbiol. 133:629–636.

285. Tosh, F. D., and L. J. Douglas. 1992. Characterization of a fucoside-binding adhesin of Candida albicans. Infect. Immun. 60:4734–4739.

286. McCourtie, J., and L. J. Douglas. 1985. Extracellular polymer of Candida albicans: isolation, analysis and role in adhesion. J. Gen. Microbiol. 131: 495–503.

287. Lee, K. K., L. Yu, D. L. Macdonald, W. Paranchych, R. S. Hodges, and R. T. Irvin. 1996. Anti-adhesin antibodies that recognize a receptor-binding motif (adhesintope) inhibit pilus/fimbrial-mediated adherence of Pseudomonas aeruginosa and Candida albicans to asialo-GM1 receptors and human buccal epithelial cell surface receptors. Can. J. Microbiol. 42:479–486.

288. Yu, L., K. K. Lee, K. Ens, P. C. Doig, M. R. Carpenter, W. Staddon, R. S. Hodges, W. Paranchych, and R. T. Irvin. 1994. Partial characterization of a Candida albicans fimbrial adhesin. Infect. Immun. 62:2834–2842.

289. Tronchin, G., J. P. Bouchara, R. Robert, and J. M. Senet. 1988. Adherence of Candida albicans germ tubes to plastic: ultrastructural and molecular studies of fibrillar adhesins. Infect. Immun. 56:1987–1993.

290. Li, R.-K., and J. E. Cutler. 1993. Chemical definition of an epitope/adhesion molecule on Candida albicans. J. Biol. Chem. 268:18293–18299.

291. Miyakawa, Y., T. Kuribayashi, K. Kagaya, M. Suzuki, T. Nakase, and Y. Fukazawa. 1992. Role of specific determinant in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect. Immun. 60:2493–2499.

292. Chaffin, W. L., Lopez-Ribot, J. L., Casanova, M., Gozalbo, D., and Martinez, J. P. (1998) Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62, 130 –180

293. Shepherd, M. G. 1987. Cell envelope of Candida albicans. Crit. Rev. Microbiol. 15:7–25.

294. M. Veen and C. Lang, Interactions of the ergosterol biosynthetic pathway with other lipid pathways Biochem. Soc. Trans. (2005) 33, (1178–1181)

295. Akins, R.A. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 2005; 42: 285-318.

296. Leber, R., Fuchsbichler, S., Klobucnikova, V. et al. Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother 2003; 47: 3890-3900.

297. Ghannoum, M.A., Rice, L. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterialn resistance. Clin Microbiol Review 1999; 12: 501-517.

298. Arikan, S, Rex, J.H. New agents for the treatment of systemic fungal infections–Current status. Expert Opin Emerg Drugs 2002; 7: 3-32.

299. 299.Mercer EI. Inhibitors of Sterol Biosynthesis and Their Applications. Prog Lipid Res. 1993;32:35 416
     

300. Baloch RI, Mercer EI. Inhibition of Sterol alpha 8-alpha 7 Isomerase and alpha 14 Reductase by Fenpropiomorph, Tridemorph, and Fenpropidin in Cell-free Enzyme Systems from Saccharomyces cerevisiae. Phytochem. 1987;26:663–668.

301. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167–193.

302. Douglas, L. J. (2003). Candida biofilms and their role in infection. Trends Microbiol 11, 30–36.

303. Mohammed A. Al-Fattani and L. Julia Douglas Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance Journal of Medical Microbiology (2006), 55, 999–1008

304. Gow N, Brown A, Odds F: Fungal morphogenesis and host invasion. Curr Opin Microbiol 2002, 5:366-371.

305. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL: Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003, 2:1053-1060.

306. Cutler J E: Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991,45:187-218.

307. Lo H J, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR: Nonfilamentous C. albicans mutants are avirulent. Cell 1997, 90:939-949.

308. Ernst J.F. (2000) Transcription factors in Candida albicans—environmental control of morphogenesis. Microbiology, 146:, 1763–1774.

309. Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquidsynthetic medium for development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153.

310. Bendel, C. M., D. J. Hess, R. M. Garni, M. Henry-Stanley, and C. L. Wells. 2003. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit. Care Med. 31:501-507.

311. Sudbery, P., N. Gow, and J. Berman. 2004. The distinct morphogenic states of Candida albicans. Trends Microbiol. 12:317-324.

312. Fan, J., V. Chaturvedi, and S. H. Shen. 2002. Identification and phylogenetic analysis of a glucose transporter gene family from the human pathogenic yeast Candida albicans. J. Mol. Evol. 55:336-346.

313. Hudson, D. A., Q. L. Sciascia, R. J. Sanders, G. E. Norris, P. J. Edwards, P. A. Sullivan, and P. C. Farley. 2004. Identification of the dialysable serum inducer of germ-tube formation in Candida albicans. Microbiology 150:3041-3049.

314. Victoria Brown,* Jessica A. Sexton, and Mark Johnston A Glucose Sensor in Candida albicans Eukaryotic Cell, October 2006, p. 1726-1737, Vol. 5, No. 10

315. Russell C, Lay KM. 1973. Natural history of Candida species and yeasts in the oral cavities of infants. Arch. Oral Biol. 18:957–62

316. Gorbach SL, Nahas L, Lerner PI,Weinstein L. 1967. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 53:845–55

317. Soll DR, Galask R, Schmid J, Hanna C, Mac K, Morrow B. 1991. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 29:1702–10

318. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939–949.

319. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2: 1053–1060.

320. Scherwitz C (1982) Ultrastructure of human cutaneous candidosis. J Invest Dermatol 78: 200–205.

321. Ray TL, Payne CD (1988) Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: A role for Candida acid proteinase. Infect Immun 56: 1942–1949.

322. Montes LF, Wilborn WH (1968) Ultrastructural features of host–parasite relationship in oral candidiasis. J Bacteriol 96: 1349–1356.

323. Garcia-Tamayo J, Castillo G, Martinez AJ (1982) Human genital candidiasis: Histochemistry, scanning and transmission electron microscopy. Acta Cytol 26: 7–14.

324. Scherwitz C (1982) Ultrastructure of human cutaneous candidosis. J Invest Dermatol 78: 200–205.

325. Garcia-Tamayo J, Castillo G, Martinez AJ (1982) Human genital candidiasis: Histochemistry, scanning and transmission electron microscopy. Acta Cytol 26: 7–14.

326. Stringaro A, Crateri P, Pellegrini G, Arancia G, Cassone A, et al. (1997) Ultrastructural localization of the secretory aspartyl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina. Mycopathologia 137: 95–105.

327. Schaller M, Korting HC, Schafer W, Bastert J, Chen W, et al. (1999) Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34: 169–180.

328. Schaller M, Bein M, Korting HC, Baur S, Hamm G, et al. (2003) The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun 71: 3227–3234.

329. De Bernardis F, Arancia S, Morelli L, Hube B, Sanglard D, et al. (1999) Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis 179: 201–208.

330. Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, et al. (2005) Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7: 499–510.

331. Drago L, Mombelli B, De Vecchi E, Bonaccorso C, Fassina MC, et al. (2000) Candida albicans cellular internalization: A new pathogenic factor? Int J Antimicrob Agents 16: 545–547.

332.Enache E, Eskandari T, Borja L, Wadsworth E, Hoxter B, et al. (1996) Candida albicans adherence to a human oesophageal cell line. Microbiology 142: 2741–2746.

333. Nadir E, Kaufshtein M (2005) Images in clinical medicine. Candida albicans in a peripheral-blood smear. N Engl J Med 353: e9.

334. Phan QT, Fratti RA, Prasadarao NV, Edwards JE Jr, Filler SG (2005) Ncadherin mediates endocytosis of Candida albicans by endothelial cells. J Biol Chem 280: 10455–10461.

335. Belanger PH, Johnston D, Fratti RA, Zhang M, Filler SG (2002) Endocytosis of Candida albicans by vascular endothelial cells is associated with tyrosine phosphorylation of specific host cell proteins. Cell Microbiol 4: 805–812.

336. Phan QT, Belanger PH, Filler SG (2000) Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68: 3485–3490.

337. Lossinsky AS, Jong A, Fiala M, Mukhtar M, Buttle KF, et al. (2006) The histopathology of Candida albicans invasion in neonatal rat tissues and in the human blood–brain barrier in culture revealed by light, scanning, transmission and immunoelectron microscopy. Histol Histopathol 21: 1029–1041.

338. Cannon RD, Hommes AR, Mason AB, Monk BC (1995). Oral Candida: clearance, colonization, or candidiasis? J Dent Res 74:1152-1161.

339. Nikawa H, Nishimura H, Yamamoto T, Samaranayake LP (1995). A novel method to study the hyphal phase of Candida albicans and to evaluate its hydrophobicity. Oral Microbiol Immunol 10:110-114.

340. Biasoli MS, Tosello ME, Magaro HM (2002). Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses 45:465-459.

341. Villar CC, Kashleva H, Dongari-Bagtzoglou A (2004). Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol Immunol 19:262-269.

342. Fukayama M, Calderone RA (1991). Adherence of cell surface mutants of Candida albicans to buccal epithelial cells and analyses of the cell surface proteins of the mutants. Infect Immun 59:1341-1345.

343. Klotz SA (1994). Adherence of Candida albicans to endothelial cells is inhibited by prostaglandin 12. Infect Immun 62:1497- 1500.

344. Diamond RD (1993). Interactions of phagocytic cells with Candida and other opportunistic fungi. Arch Med Res 24:361-369. 345.

345. Bouchara J-P, Tronchin G, Annaix V, Robert R, Senet J-M (1990). Laminin receptors on Candida albicans germ tubes. Infect Immun 58:48-54.

346. Klotz SA, Smith RL (1991). A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis 163:604-610.

347. Klotz SA, Rutten MJ, Smith RL, Babcock SR, Cunningham MD (1993). Adherence of Candida albicans to immobilized extracellular matrix proteins is mediated by calciumdependent surface glycoproteins. Microb Pathogen 14:133- 147.

348. L6pez-Ribot J-L, Chaffin WL (1994). Binding of the extracellular matrix component entactin to Candida albicans. Infect Immun 62:4564-4571.

348. Negre E, Vogel T, Levanon A, Guy R, Walsh TJ, Roberts DD (1994). The collagen binding domain of fibronectin contains a high affinity binding site for Candida albicans. r Biol Chem 269:22039-22045.

349. Hostetter MK (1994). Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev 7:29-42.

350. Santoni G, Gismondi A, Liu JH, Punturieri A, Santoni A, Frati L, et al. (1994). Candida albicans expresses a fibronectin receptor antigenically related to x531 integrin. Microbiol 140:2971-2979.

Références suite.

© Frédéric Born - Médecin-dentiste - Lausanne